EPX-100 (Clemizole Hydrochloride) som supplerende terapi hos børn med Lennox Gastaut syndrom
Et 20-ugers multicenter, randomiseret, dobbeltblindet, placebokontrolleret, bevis på konceptforsøg med EPX-100 (Clemizole Hydrochloride) som supplerende terapi hos børn med Lennox-Gastaut syndrom
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in children and adult participants with Lennox-Gastaut syndrome (LGS).
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCl as adjunctive therapy in children and adult participants with LGS.
The study will consist of an Observational Period, a Double-Blind (DB) Period, and an optional Open-Label Extension (OLE) Period.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Fase 3
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Juby Philip
- Telefonnummer: (302) 559-4320
- E-mail: clinicaltrials@harmonybiosciences.com
Undersøgelse Kontakt Backup
- Navn: Cindy Sandy
- Telefonnummer: (317) 258-7262
- E-mail: clinicaltrials@harmonybiosciences.com
Studiesteder
-
-
Arkansas
-
Little Rock, Arkansas, Forenede Stater, 72202
- Aktiv, ikke rekrutterende
- Arkansas Children's Hospital
-
-
California
-
Orange, California, Forenede Stater, 92868
- Aktiv, ikke rekrutterende
- UC Irvine Medical Center
-
-
Florida
-
Miami, Florida, Forenede Stater, 33136
- Rekruttering
- University of Miami Miller School of Medicine
-
Kontakt:
- Brett Alonso Cardenas
- Telefonnummer: 305-243-3100
- E-mail: bac301@med.miami.edu
-
Ledende efterforsker:
- Kamil Detyniecki, MD
-
Orlando, Florida, Forenede Stater, 32804
- Rekruttering
- AdventHealth Innovation Tower
-
Ledende efterforsker:
- Holly Skinner, DO
-
Orlando, Florida, Forenede Stater, 34746
- Suspenderet
- Rare Disease Research
-
Winter Park, Florida, Forenede Stater, 32789
- Aktiv, ikke rekrutterende
- Pediatric Neurology and Epilepsy Specialists
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60611
- Rekruttering
- Re:Cognition Health
-
Kontakt:
- Antonio Iglesias, MD
- Telefonnummer: 312-971-3318
- E-mail: aiglesias@re-cognitionhealth.com
-
Ledende efterforsker:
- Antonio Iglesias, MD
-
-
Kentucky
-
Louisville, Kentucky, Forenede Stater, 40202
- Rekruttering
- Norton Children's Medical Center
-
Ledende efterforsker:
- Jaime Shoup, MD
-
Kontakt:
- Madeline McGinty-Holmes
- Telefonnummer: 502-629-5568
- E-mail: madeline.mcginty-holmes@louisville.edu
-
-
Michigan
-
Detroit, Michigan, Forenede Stater, 48202
- Aktiv, ikke rekrutterende
- Henry Ford Hospital
-
-
Minnesota
-
Roseville, Minnesota, Forenede Stater, 55102
- Rekruttering
- Minnesota Epilepsy Group, P.A.
-
Kontakt:
- Sarah Ellis, MD
- Telefonnummer: 651-377-8319
- E-mail: sellis@mnepilepsy.net
-
Ledende efterforsker:
- Stephanie Ahrens, MD
-
-
Nebraska
-
Omaha, Nebraska, Forenede Stater, 68114
- Rekruttering
- Children's Nebraska
-
Kontakt:
- Sookyong Koh, MD, PhD
- Telefonnummer: 773-929-4445
- E-mail: skoh@childrensnebraska.org
-
Ledende efterforsker:
- Sookyong Koh
-
-
New Jersey
-
Marlboro, New Jersey, Forenede Stater, 07746
- Rekruttering
- Tekton Research
-
Ledende efterforsker:
- Amor Mehta, MD
-
Kontakt:
- Aimee Kinlan
- Telefonnummer: 626-218-8294
- E-mail: aimee.kinlan@tektonresearch.com
-
-
New York
-
New York, New York, Forenede Stater, 10021
- Rekruttering
- Weill Cornell Medicine/New York Presbyterian Hospital
-
Kontakt:
- Lundy Santil
- Telefonnummer: Ext. 198 800-785-3150
- E-mail: ludny.saintil@thermofisher.com
-
Kontakt:
- Asim Shahid
- E-mail: los9075@med.cornell.edu
-
Ledende efterforsker:
- Asim Shahid, MD
-
New York, New York, Forenede Stater, 10016-4852
- Rekruttering
- NYU Comprehensive Epilepsy Center - BRANY - PPDS
-
Ledende efterforsker:
- Dana Price
-
-
North Carolina
-
Charlotte, North Carolina, Forenede Stater, 28211
- Rekruttering
- On-Site Clinical Solution
-
Ledende efterforsker:
- Robert Nahouraii
-
Kontakt:
- Ludny Saintil
- Telefonnummer: 198 800-785-3150
- E-mail: ludny.santil@thermofischer.com
-
Charlotte, North Carolina, Forenede Stater, 28207
- Rekruttering
- Atrium Health STRIVE Research
-
Kontakt:
- Jessica Lindley
- E-mail: Jessica.Lindley@atriumhealth.org
-
Ledende efterforsker:
- Ravi Singh, MD
-
Durham, North Carolina, Forenede Stater, 27705
- Rekruttering
- Duke University Medical Center
-
Kontakt:
- Muhammad Zafar, MD
- E-mail: muhammad.zafar@duke.edu
-
Ledende efterforsker:
- Muhammad Zafar, MD
-
Morrisville, North Carolina, Forenede Stater, 27560
- Rekruttering
- PPD Virtual-Science 37, Inc.
-
Ledende efterforsker:
- Antonio Iglesias, MD
-
Kontakt:
- Victoria Taylor
- Telefonnummer: 615-707-9148
- E-mail: victoria.taylor@science37.com
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Rekruttering
- Children's Hospital of Philadelphia
-
Ledende efterforsker:
- Eric Marsh, MD
-
-
Texas
-
Dallas, Texas, Forenede Stater, 75235
- Rekruttering
- Children's Health Specialty Center
-
Ledende efterforsker:
- Charuta Joshi
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- UTHealth Houston
-
Kontakt:
- Antoinette Bernal-Tent
- Telefonnummer: 713-500-7105
- E-mail: Antoinette.BernalTent@uth.tmc.edu
-
Ledende efterforsker:
- Mary Koenig, MD
-
-
Utah
-
Salt Lake City, Utah, Forenede Stater, 84132
- Rekruttering
- Clinical Neurosciences Center
-
Ledende efterforsker:
- Angela Peters, MD
-
-
-
-
Andhra Pradesh
-
Hyderabad, Andhra Pradesh, Indien, 500082
- Rekruttering
- Nizams Institute of Medical Sciences
-
Ledende efterforsker:
- Surya Prabha Turaga
-
Hyderabad, Andhra Pradesh, Indien, 500081
- Rekruttering
- Yashoda Hospitals Hitec City
-
Ledende efterforsker:
- Lokesh Lingappa
-
-
Gujarat
-
Ahmedabad, Gujarat, Indien, 380054
- Rekruttering
- Royal Institute of Child Neurosciences
-
Ledende efterforsker:
- Nitish Vora
-
Surat, Gujarat, Indien, 395002
- Rekruttering
- Saachi Children Hospital
-
Ledende efterforsker:
- Ritesh Shah
-
-
Kerala
-
Calicut, Kerala, Indien, 673016
- Rekruttering
- Aster Malabar Institute of Medical Sciences Ltd
-
Ledende efterforsker:
- Smilu Mohanlal
-
-
-
-
-
Catanzaro, Italien, 88100
- Rekruttering
- Azienda Ospedaliera Universitaria Renato Dulbecco - AO Mater Domini
-
Ledende efterforsker:
- Antonio Gambardella
-
Florence, Italien, 50139
- Rekruttering
- Azienda Ospedaliero Universitaria A Meyer
-
Ledende efterforsker:
- Renzo Guerrini
-
Milan, Italien, 20133
- Rekruttering
- Fondazione IRCCS Istituto Neurologico Carlo Besta
-
Ledende efterforsker:
- Giuseppe Didato
-
Pavia, Italien, 27100
- Rekruttering
- Fondazione Istituto Neurologico Nazionale Casimiro Mondino IRCCS
-
Ledende efterforsker:
- Elena Tartara
-
-
Liguria
-
Genoa, Liguria, Italien, 16147
- Rekruttering
- IRCCS Istituto Giannina Gaslini
-
Ledende efterforsker:
- Maria Margherita Mancardi
-
Genoa, Liguria, Italien, 16132
- Rekruttering
- IRCCS Azienda Ospedaliera Metropolitan
-
Ledende efterforsker:
- Flavio Villani
-
-
Molise
-
Pozzilli, Molise, Italien, 86077
- Rekruttering
- IRCCS Istituto Neurologico Mediterraneo Neuromed
-
Ledende efterforsker:
- Alfredo D'Aniello
-
-
-
-
-
Beijing, Kina, 100045
- Rekruttering
- Beijing Children's Hospital, Capital Medical University - PIN
-
Ledende efterforsker:
- Hui Xiong
-
Beijing, Kina, 100034
- Rekruttering
- Peking University First Hospital - Changqiao Campus
-
Ledende efterforsker:
- Yuwu Jiang
-
Beijing, Kina, 100034
- Rekruttering
- Peking University First Hospital - Daxing Campus
-
Ledende efterforsker:
- Yuwu Jiang
-
Changchun, Kina, 130021
- Rekruttering
- The First Hospital of Jilin University
-
Ledende efterforsker:
- Jianmin Liang
-
Changsha, Kina, 410007
- Rekruttering
- Hunan Children's Hospital
-
Ledende efterforsker:
- Sai Yang
-
Chengdu, Kina, 610041
- Rekruttering
- West China Second University Hospital, Sichuan University - Huaxi Campus
-
Ledende efterforsker:
- Rong Luo
-
Chengdu, Kina, 610073
- Rekruttering
- Chengdu Women's and Children's Central Hospital
-
Ledende efterforsker:
- Li Yan
-
Chongqing, Kina, 400014
- Rekruttering
- Children's Hospital of Chongqing Medical University
-
Ledende efterforsker:
- Li Jiang
-
Guangzhou, Kina, 510260
- Rekruttering
- The Second Affiliated Hospital of Guangzhou Medical University
-
Ledende efterforsker:
- Xiaorong Liu
-
Guiyang, Kina, 550004
- Rekruttering
- The Affiliated Hospital of Guizhou Medical University
-
Ledende efterforsker:
- Rong Ai
-
Jinan, Kina, 250012
- Rekruttering
- Qilu Hospital of Shandong University
-
Ledende efterforsker:
- Baomin Li
-
Nanchang, Kina, 330006
- Rekruttering
- Jiangxi Provincial Children's Hospital
-
Ledende efterforsker:
- Yong Chen
-
Shenzhen, Kina, 518000
- Rekruttering
- Shenzhen Children's Hospital
-
Ledende efterforsker:
- Dezhi Cao
-
Wuhan, Kina, 430015
- Rekruttering
- Wuhan Children's Hospital
-
Ledende efterforsker:
- Dan Sun
-
Xi'an, Kina, 710004
- Rekruttering
- The Second Affiliated Hospital of Xi'an Jiaotong University
-
Ledende efterforsker:
- Lin Yang
-
Xuzhou, Kina, 221006
- Rekruttering
- Xuzhou Children's Hospital
-
Ledende efterforsker:
- Xiaoming Liu
-
-
Hunan
-
Changsha, Hunan, Kina, 410008
- Rekruttering
- Xiangya Hospital Central South University
-
Ledende efterforsker:
- Jing Peng
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Kina, 200062
- Rekruttering
- Children's Hospital of Shanghai
-
Ledende efterforsker:
- Simei Wang
-
-
-
-
Lesser Poland Voivodeship
-
Krakow, Lesser Poland Voivodeship, Polen, 30-363
- Rekruttering
- Centrum Medyczne Plejady Magdalena Celinska
-
Ledende efterforsker:
- Marta Zolnowska, MD
-
-
Lower Silesian Voivodeship
-
Wroclaw, Lower Silesian Voivodeship, Polen, 50-414
- Rekruttering
- Premium Clinic Wrocław Centrum Medyczne
-
Ledende efterforsker:
- Monika Sluzewska-Niedzwiedz
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, Polen, 02-829
- Rekruttering
- Neurosphera
-
Ledende efterforsker:
- Beata Zwolinska
-
-
-
-
-
Bucharest, Rumænien, 050098
- Rekruttering
- Emergency University Hospital
-
Ledende efterforsker:
- Ioana Raluca Mindruta
-
Bucharest, Rumænien, 041408
- Rekruttering
- Centrul National Clinic De Recuperare Neuropsihomotorie Copii Robanescu-Padure
-
Ledende efterforsker:
- Madalina Leanca
-
Iași, Rumænien, 700309
- Rekruttering
- Sf. Maria Children Emergency Clinical Hospital Iasi
-
Ledende efterforsker:
- Ioana Grigore
-
-
-
-
-
Belgrade, Serbien, 11000
- Rekruttering
- Mother and Child Health Care Institute of Serbia Dr Vukan Cupic
-
Ledende efterforsker:
- Biljana Vucetic Tadic
-
Belgrade, Serbien, 11000
- Rekruttering
- Childrens University Hospital
-
Ledende efterforsker:
- Dimitrije Nikolic
-
Niš, Serbien, 18 000
- Rekruttering
- University Clinical Center Nis
-
Ledende efterforsker:
- Tatjana Tosic
-
Novi Sad, Serbien, 21000
- Rekruttering
- Children and Youth Health Care Institute of Vojvodina
-
Ledende efterforsker:
- Tatjana Redzek Mudrinic
-
-
-
-
-
Barcelona, Spanien, 08025
- Rekruttering
- Hospital de La Santa Creu i Sant Pau
-
Ledende efterforsker:
- Alba Sierra-Marcos
-
Barcelona, Spanien, 08035
- Rekruttering
- Hospital Universitario Vall d'Hebron - PPDS
-
Ledende efterforsker:
- Manuel Toledo Argany
-
Madrid, Spanien, 28009
- Rekruttering
- Hospital Infantil Universitario Niño Jesus - PIN
-
Ledende efterforsker:
- Victor Soto Insuga
-
Málaga, Spanien, 29010
- Rekruttering
- Hospital Regional Universitario de Malaga - Hospital General
-
Ledende efterforsker:
- Pedro Serrano
-
Pamplona, Spanien, 31008
- Rekruttering
- Hospital Universitario de Navarra
-
Ledende efterforsker:
- Sergio Aguilera Albesa
-
Seville, Spanien, 41013
- Rekruttering
- Centro de Neurologia Avanzada
-
Ledende efterforsker:
- Juan Jesús Rodríguez Uranga, MD
-
-
-
-
-
Ortahisar, Tyrkiet (Türkiye), 61080
- Rekruttering
- Karadeniz Teknik Universitesi Farabi Hastanesi
-
Ledende efterforsker:
- Ali Cansu
-
-
Eskişehir
-
Odunpazari, Eskişehir, Tyrkiet (Türkiye), 26040
- Rekruttering
- Eskisehir Osmangazi Universitesi Saglik Uygulama ve Arastirma Hastanesi
-
Ledende efterforsker:
- Kursat Carman
-
-
-
-
Hajdú-Bihar
-
Debrecen, Hajdú-Bihar, Ungarn, 4032
- Rekruttering
- Debreceni Egyetem Klinikai Kozpont Nagyerdei Campus
-
Ledende efterforsker:
- Monika Bessenyei
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Key Inclusion Criteria:
-
Males or females, ages ≥2 to ≤55 years, at the time of Screening.
-
Participant/parent/legal authorized representative (LAR) willing and able to give written informed consent/assent.
-
Diagnosis of LGS, including:
- Evidence of at least one type of countable major motor seizure.
- History of electroencephalogram (EEG) consistent with LGS (abnormal background activity, and one of the following: 1) slow spike-wave discharges [<2.5 Hz], or 2) paroxysmal fast activity during sleep).
- Abnormal cognitive development.
- Onset of seizures at 11 years of age or younger.
Key Exclusion Criteria:
- Known sensitivity, allergy, or previous exposure to clemizole HCl.
- Known history of long QT syndrome or any significant history of a serious abnormality of the electrocardiogram (ECG) (e.g., recent myocardial infarction, clinically significant arrhythmia).
- Family history of sudden cardiac death, unexplained death, or death from a primary dysrhythmia potentially associated with QT prolongation in any family member.
- Seizures secondary to illicit drug or alcohol use, infection, neoplasm, demyelinating disease, degenerative neurological disease, or progressive central nervous system disease, metabolic illness, recent anoxic episode within the last 6 months requiring resuscitation, or progressive degenerative disease or any other condition, which in the opinion of the investigator, could affect seizure control.
- Epilepsy surgery planned during the study or epilepsy surgery within 6 months prior to Screening.
- Concomitant use of fenfluramine.
- Prior or concomitant use of lorcaserin.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Placebo komparator: Placebo
Participants will receive their first dose of study drug following randomization. |
Placebo will be administered as an oral solution. |
|
Eksperimentel: Double-blind clemizole HCl
Participants will receive their first dose of study drug following randomization. |
Clemizole HCl will be administered as an oral solution.
Andre navne:
|
|
Eksperimentel: Open-label clemizole HCl
Eligible participants who complete the DB Period will have the option to continue in the OLE Period, during which they will receive clemizole HCl for up to 3 years. |
Clemizole HCl will be administered as an oral solution.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Percent Change in CMMS-28
Tidsramme: From Baseline Period up to 16 weeks
|
Percent change in CMMS-28 from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of Participants with ≥50% Reduction in CMMS-28
Tidsramme: From Baseline Period up to 16 weeks
|
Proportion of participants with ≥50% reduction in CMMS-28 from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Percent Change in CMMS-28 Seizure-free Days
Tidsramme: From Baseline Period up to 16 weeks
|
Percent change in CMMS-28 seizure-free days from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Clinical Global Impression of Change (CGI-C) Score
Tidsramme: Week 16
|
CGI-C score at the end of the DB Period |
Week 16
|
|
Caregiver Global Impression of Change (CaGI-C) Score
Tidsramme: Week 16
|
CaGI-C score at the end of the DB Period |
Week 16
|
|
Caregiver Global Impression of Change in Seizure Intensity/Duration (CaGI-CSID) Score
Tidsramme: Week 16
|
CaGI-CSID score at the end of the DB Period |
Week 16
|
|
Change in Quality of Life Inventory (QI)-Disability Score
Tidsramme: From Baseline Period up to 16 weeks
|
Change in QI-disability score from Baseline to the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Percent Change per 28 Days in the Number of Seizure Free Days
Tidsramme: From Baseline Period up to 16 weeks
|
Percent change per 28 days in the number of seizure-free days (based on all seizure types) from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Percent Change in CMMS-28
Tidsramme: From Baseline Period up to 12 weeks
|
Percent change in CMMS-28 from the Baseline Period through the end of the DB Maintenance Phase only |
From Baseline Period up to 12 weeks
|
|
Proportion of Participants with ≥50% Reduction in CMMS-28
Tidsramme: From Baseline Period up to 12 weeks
|
Proportion of participants with ≥50% reduction in CMMS-28 from the Baseline Period through the end of the DB Maintenance Phase only |
From Baseline Period up to 12 weeks
|
|
Incidence of Treatment-Emergent Adverse Events (TEAEs)
Tidsramme: From the first dose administration of study drug up to end of the study, approximately up to 172 weeks
|
Incidence of TEAEs will be compared among the treatment groups |
From the first dose administration of study drug up to end of the study, approximately up to 172 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Studieleder: Amit Ray, MD, Harmony Biosciences Management, Inc.
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Epileptiske syndromer
- Neurologiske manifestationer
- Hjernesygdomme
- Sygdomme i centralnervesystemet
- Sygdomme i nervesystemet
- Genetiske sygdomme, medfødte
- Epilepsi
- Medfødte, arvelige og neonatale sygdomme og abnormiteter
- Patologiske tilstande, tegn og symptomer
- Tegn og symptomer
- Anfald
- Lennox Gastaut syndrom
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- EPX-100-003
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .